Ahrens Investment Partners’s CareDx CDNA Stock Holding History

Ahrens Investment Partners’s Portfolio CDNA Stock Details CDNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-2,800	Closed	-$203K	–	216
2020 Q4	$203K	Buy	+2,800	New	+$162K	0.11%	167

Other funds holding CDNA

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

MCMC

Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Ahrens Investment Partners's CDNA Position: Q1 2021 in Review

Ahrens Investment Partners sold out of CareDx (CDNA) in Q1 2021, closing a stake of 2,800 shares — an estimated $203K sold.

Ahrens Investment Partners first reported a position in CDNA in Q4 2020 and held it in 1 quarter. The position peaked at $203K in Q4 2020. 245 funds tracked by Wall St. Rank hold CDNA as of Q1 2021.

Ahrens Investment Partners reported no remaining CareDx position as of Q1 2021 after selling out during the quarter.
Ahrens Investment Partners sold 2,800 CareDx shares in Q1 2021, an estimated $203K.
Ahrens Investment Partners first reported a position in CareDx in Q4 2020 and held it in 1 quarter.
Ahrens Investment Partners's CareDx position peaked at $203K in Q4 2020.
245 funds tracked by Wall St. Rank held CareDx as of Q1 2021.

Based on Ahrens Investment Partners's 13F filing for Q1 2021, filed 5 May 2021.